Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells

Transfusion

Volumn 38, Issue 2, 1998, Pages 199-208

  Beguin, Y ^a   Baudoux, E ^a   Sautois, B ^a   Fraipont, V ^a   Schaaf Lafontaine, N ^a   Pereira, M ^a   Paulus, J M ^a   Sondag, D ^a   Fillet, G ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; TRANSFERRIN RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD CELL COUNT; BONE MARROW TRANSPLANTATION; BURST FORMING UNIT E; CANCER PATIENT; CELL FRACTIONATION; CELL SUBPOPULATION; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; ERYTHROPOIESIS; FEMALE; HEMATOPOIESIS; HUMAN; LYMPHOMA; MALE; MULTIPLE MYELOMA; RETICULOCYTOSIS; SOLID TUMOR; STEM CELL TRANSPLANTATION; THROMBOCYTOPOIESIS;

EID: 0031919269     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1998.38298193106.x     Document Type: Article

References (22)

1. Schmitz N, Linch DC, Dreger P, et al. Randomised trial of filgastrim-mobilised peripheral blood progenitor cell transplantation versus autologus bone-marrow transplantation in lymphoma patients. Lancet 1996;347:353-7.
2. Moolten DN. Peripheral blood stem cell transplant: future directions. Semin Oncol 1995;22:271-90.
3. Schiller G, Vescio R, Freytes C, et al. Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995;86:390-7.
4. Gorin NC, Lopez M, Laporte JP, et al. Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood 1995;85:1647-54.
5. Lemoli RM, Fortuna A, Motta MR, et al. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells. Blood 1996;87:1625-34.
6. Shpall EJ, Jones RB, Bearman SI, et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 1994;12:28-36.
7. Mahé B, Milpied N, Hermouet S, et al. G-CSF alone mobilizes sufficient peripheral blood CD34+ cells for positive selection in newly diagnosed patients with myeloma. Br J Haematol 1996;92:263-8.
8. Johnson RJ, Owen RG, Smith GM, et al. Peripheral blood stem cell transplantation in myeloma using CD34 selected cells. Bone Marrow Transplant 1996;17:723-7.
9. Andrews RG, Bryant EM, Bartelmez SH, et al. CD34+ marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons. Blood 1992;80:1693-701.
10. Berenson RJ, Andrews RG, Bensinger WI, et al. Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest 1988;81:951-5.
11. Berenson RJ, Bensinger WI, Hill RS, et al. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 1991;77:1717-22.
12. Van Bockstaele DR, Peetermans ME. 1,3′-diethyl-4,2′-quinolylthiacyanine iodide as a "thiazole orange" analogue for nucleic acid staining. Cytometry 1989;10:214-6.
13. Huebers HA, Beguin Y, Pootrakul P, et al. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood 1990;75:102-7.
14. Beguin Y, Clemons GK, Pootrakul P, Fillet G. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood 1993;81:1067-76.
15. Brugger W, Henschler R, Heimfeld S, et al. Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 1994;84:1421-6.
16. Watts MJ, Jones HM, Sullivan AM, et al. Accessory cells do not contribute to G-CSF or IL-6 production nor to rapid haematological recovery following peripheral blood stem cell transplantation. Br J Haematol 1995;91:767-72.
17. Hassan MT, Stockschlader M, Kruger W, et al. G-CSF administration following peripheral blood selected CD34-positive cell autologous transplantation accelerates haematological recovery after myeloablative therapy (letter). Br J Haematol 1996;92:1027-9.
18. Williams SF, Lee WJ, Bender JG, et al. Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. Blood 1996;87:1687-91.
19. Brugger W, Heimfeld S, Berenson RJ, et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 1995;333:283-7.
20. Muench MO, Firpo MT, Moore MA. Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential. Blood 1993;81:3463-73.
21. Peters SO, Kittler EL, Ramshaw HS, Quesenberry PJ. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 1996;87:30-7.
22. McDonald TP, Sullivan PS. Megakaryocytic and erythrocytic cell lines share a common precursor cell. Exp Hematol 1993;21:1316-20.